By Chris Wack
Cellebrite shares were down 7% to $18.71 after the company reported first-quarter revenue that was below analysts' expectations.
The technology company said it had quarterly revenue of $107.5 million, compared to $89.6 million in the same quarter last year. Analysts polled by FactSet were looking for revenue of $109.3 million.
The company swung to a profit this quarter, seeing earnings of $17.4 million, or 7 cents a share, compared with a loss of $71.4 million, or 36 cents a share, last year. Analysts were expecting earnings of $11.6 million, or 5 cents a share.
Adjusted earnings were 10 cents a share, compared with the 7 cents a share analysts had forecast.
Cellebrite said its subscription revenue was $95.8 million in the first quarter, up 21% year-over-year, and annual recurring revenue was $408 million, up 23% year-over-year.
The company is expecting quarterly revenue of $110 million to $116 million, compared with the $115.3 million analysts are looking for. For 2025, Cellebrite is looking for revenue of $470 million to $485 million, while analysts are forecasting 2025 revenue of $484.2 million.
Cellebrite said its outlook for the second quarter reflects its expectation that the current U.S. Federal spending environment will persist into the second quarter. Its 2025 revenue target now reflects the timing of net new business in the second half of its year, combined with lower anticipated one-time professional services revenue from the U.S. Federal vertical.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
May 14, 2025 10:41 ET (14:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.